ADO and neoplasm: Notably, enzymes such as adenosine deaminase and adenosine kinase regulate the final metabolic conversion of ADO and the activation level of ADO receptors; however, their role in tumor development is unclear, making this a therapeutic target worth exploring in the ADO pathway (13).